The U.S. Maternal and Child Health Bureau (MCHB) awarded a $1,899,958 Project Grant under the Maternal and Child Health Federal Consolidated Programs (CFDA 93.110) to Boston Medical Center Corporation (BMC) and Proof Alliance to create the SAFEST Choice National Learning Collaborative. This program aims to improve the ability of primary care providers (PCPs) and their teams to screen for alcohol use during pregnancy, provide brief interventions to prevent prenatal alcohol exposure (PAE), and...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) grant program, aims to develop and assess the feasibility of the "Families Moving Forward (FMF) Bridges" early intervention for infants and toddlers affected by prenatal alcohol exposure (PAE) or fetal alcohol spectrum disorders (FASD). The $231,364 award will fund a two-phase study to examine the feasibility of implementing the FMF...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $187,143 Project Grant (CFDA 93.273 - Alcohol Research Programs) to the University of California, San Diego (UCSD) to conduct a pilot study on parental alcohol and cannabis use before, during, and after pregnancy. The study aims to 1) characterize maternal and paternal patterns of alcohol and cannabis use, 2) characterize paternal patterns of alcohol and cannabis use, and 3) model individual and joint exposure...
This Project Grant award, funded by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program, supports a comprehensive $398,972 study on improving healthcare quality and equity for newborns with prenatal substance exposure. The study, conducted by the University of California, Davis in collaboration with the Better Outcomes through Research for Newborns (BORN) network and the EMPOWER stakeholder group, aims to:...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, is focused on exploring the role of choline-related genetic polymorphisms in influencing behavioral outcomes for individuals with prenatal alcohol exposure (PAE) and fetal alcohol spectrum disorders (FASD). The $479,164 award to the University of North Carolina at Chapel Hill has two main objectives: 1) to test the...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, supports research to investigate the mechanistic basis for fetal growth deficits associated with prenatal alcohol exposure (PAE). The $317,534.10 award, with a project period from August 15, 2024 to July 31, 2027, will be used by the University of North Carolina at Chapel Hill to quantify the impact of alcohol on maternal-fetal...
This Project Grant award of $481,428 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support the "Translating Research into Practice on Alcohol and Polysubstance Use Disorders by Educating the Interprofessional Primary Care Team" project. The key objectives are to 1) improve the capacity of primary care providers in federally qualified health centers and safety net settings to apply best practices in preventing,...
This federal Project Grant award, provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273), aims to develop treatments for cognitive deficits caused by fetal alcohol exposure. The $725,192 award will fund a series of studies to characterize the dose-response curve of vinpocetine, a compound that has shown promise in improving neuronal plasticity in animal models of fetal alcohol spectrum disorders (FASD). The initial R61 phase...
The U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $894,841 Project Grant under CFDA 93.243 (Substance Abuse and Mental Health Services Projects of Regional and National Significance) to the Indiana Family and Social Services Administration (FSSA), doing business as Medicaid. The grant will expand the successful Indiana Pregnancy Promise Program, which addresses opioid and broader substance use disorder among pregnant individuals, to serve an additional 300...
This $182,199 federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund a community-based adaptation of the "Mentor Moms" intervention to address alcohol use and HIV risk among pregnant and lactating people in South Africa. The key products and services to be delivered include: A mixed methods assessment to identify perceptions and facilitators of alcohol use reduction among...
BUILDING PARTNERSHIPS AND EQUIPPING FAMILY PHYSICIANS TO ADDRESS PRENATAL ALCOHOL AND OTHER SUBSTANCE USE AND FETAL ALCOHOL SPECTRUM DISORDERS - FASDS ARE THE LEADING PREVENTABLE CAUSE OF BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES. ALCOHOL USE IN PREGNANCY IS THE CAUSE OF FETAL ALCOHOL SPECTRUM DISORDERS (FASDS), A RANGE OF LIFELONG CONDITIONS THAT INCLUDE PHYSICAL ABNORMALITIES, BEHAVIORAL PROBLEMS, AND INTELLECTUAL DISABILITIES.8 FAMILY PHYSICIANS ARE UNIQUELY POSITIONED TO PROVIDE CARE TO THOSE OF REPRODUCTIVE AGE, THEIR CHILDREN, AND FAMILIES FROM "WOMB TO TOMB." THE AMERICAN ACADEMY OF FAMILY PHYSICIANS (AAFP) PROPOSES THE "BUILDING PARTNERSHIPS AND EQUIPPING FAMILY PHYSICIANS TO ADDRESS PRENATAL ALCOHOL AND OTHER SUBSTANCE USE AND FASDS" PROJECT TO EQUIP FAMILY PHYSICIANS WITH THE KNOWLEDGE, SKILLS, AND RESOURCES TO: 1) DECREASE PRENATAL ALCOHOL AND OTHER SUBSTANCE USE AMONG WOMEN OF REPRODUCTIVE AGE, 2) IMPROVE SUPPORT SERVICES AND ACCESS TO CARE FOR IMPACTED WOMEN AND FAMILIES, 3) AND IMPROVE IDENTIFICATION AND MANAGEMENT OF CHILDREN/FAMILIES WITH FASDS. THIS MULTI-FACETED PROJECT WILL UTILIZE THE FOLLOWING STRATEGIES: (1) PARTICIPATE IN A MULTIDISCIPLINARY FASD CHAMPIONS NETWORK, (2) DEVELOP AND DISSEMINATE FASD-RELATED MESSAGING THROUGH NATIONAL AND REGIONAL SYSTEMS, (3) BUILD CAPACITY TO SUPPORT CLINICAL AND PUBLIC HEALTH PARTNERS AND RESOURCES TO REACH AFFECTED POPULATIONS, (4) PROVIDE ONGOING EVALUATION OF MEMBERS' KNOWLEDGE, PRACTICES, REFERRAL PATTERNS, AND AWARENESS OF RESOURCES, (5) DEVELOP AND PROMOTE ENDURING FAMILY PHYSICIAN EDUCATION ABOUT SERVING POPULATIONS OF REPRODUCTIVE AGE, AND (6) PROMOTE FASD-INFORMED MESSAGING. STRATEGIES 1 & 2. PARTICIPATE IN A COHESIVE, MULTIDISCIPLINARY FASD CHAMPIONS NETWORK TO INCREASE SUPPORT AND SHARE MESSAGING AND RESOURCES. CREATE AND SHARE MESSAGING THROUGH THESE NETWORKS TO PROMOTE EVIDENCE-BASED RECOMMENDATIONS ABOUT PREVENTION OF ALCOHOL AND OTHER SUBSTANCE USE AMONG PEOPLE WHO ARE PREGNANT OR MIGHT BE PREGNANT AND EARLY IDENTIFICATION AND MANAGEMENT OF CHILDREN LIVING WITH FASDS. OUTCOMES: INCREASED THE PUBLIC KNOWLEDGE THROUGH TARGETED MESSAGING ON THE RISKS OF PRENATAL ALCOHOL AND OTHER SUBSTANCE USE. IMPROVED INTEGRATION OF EVIDENCE-BASED FASD-RELATED STRATEGIES IN FAMILY MEDICINE. STRATEGY 3. BUILD COMMUNITY, STATE, AND LOCAL CAPACITY TO LINK CLINICAL AND PUBLIC HEALTH PARTNERS TO REACH AFFECTED POPULATIONS WITH EFFECTIVE PROGRAMS AND PRACTICES. OUTCOMES: IMPROVED CAPACITY OF STATE CHAPTERS AND FAMILY PHYSICIANS TO REACH AFFECTED POPULATIONS WITH RELEVANT, EVIDENCE-BASED MESSAGING AND SERVICES AND LINK THOSE AFFECTED TO APPROPRIATE COMMUNITY RESOURCES. STRATEGY 4. EVALUATE THE EFFECTIVENESS OF PROJECT STRATEGIES, INCLUDING MEMBERSHIP KNOWLEDGE, PRACTICES, REFERRAL PATTERNS, AND AWARENESS OF RESOURCES THROUGH AAFP CHANNELS. OUTCOMES: INCREASE IN MEMBERS' KNOWLEDGE, PRACTICES, REFERRAL PATTERNS, AND AWARENESS OF RESOURCES. INCREASED MEMBER ENGAGEMENT WITH RESOURCES AND TOOLS AVAILABLE. STRATEGY 5. DEVELOP AND SHARE INNOVATIVE EDUCATIONAL CONTENT ON PRENATAL ALCOHOL AND OTHER SUBSTANCE USE, SCREENING AND BRIEF INTERVENTION FOR ALCOHOL AND OTHER SUBSTANCES, AS WELL AS THE IDENTIFICATION/MANAGEMENT OF CHILDREN LIVING WITH FASDS. OUTCOMES: INCREASED USE OF EVIDENCE-BASED INFORMATION AND RESOURCES ON PRENATAL ALCOHOL AND OTHER SUBSTANCE USE. INCREASED KNOWLEDGE RELATED TO THE RISK OF PRENATAL ALCOHOL AND OTHER SUBSTANCE USE. INCREASED INCORPORATION OF CONTENT RELATED TO CLINICAL RECOMMENDATIONS AND ORGANIZATIONAL POLICIES INTO ORGANIZATIONAL RESOURCES AND ACCREDITED CME MATERIALS. STRATEGY 6. DEVELOP MESSAGING AND RESOURCES BASED ON FAMILIES WHO HAVE BEEN AFFECTED BY ALCOHOL AND OTHER SUBSTANCE USE DURING PREGNANCY AND FASDS. OUTCOMES: INCREASED KNOWLEDGE RELATED TO THE RISK OF PRENATAL ALCOHOL AND OTHER SUBSTANCE USE. INCREASED LINKAGE OF PEOPLE AT RISK OF PRENATAL ALCOHOL AND OTHER SUBSTANCE USES AS WELL AS FAMILIES LIVING WITH FASDS TO LOCAL SERVICES, TREATMENT, SU